Affinity Asset Advisors’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-191,127
Closed -$1.63M 109
2024
Q2
$1.63M Buy
+191,127
New +$1.7M 0.19% 69
2021
Q4
Sell
-38,814
Closed -$1.13M 75
2021
Q3
$1.13M Buy
38,814
+8,814
+29% +$293K 0.28% 53
2021
Q2
$1.04M Sell
30,000
-50,000
-63% -$1.59M 0.37% 54
2021
Q1
$2.53M Buy
80,000
+15,000
+23% +$610K 0.86% 34
2020
Q4
$3.07M Buy
+65,000
New +$3.02M 1.63% 19

Other funds holding ZYME

Affinity Asset Advisors's ZYME Position: Q3 2024 in Review

Affinity Asset Advisors sold out of Zymeworks (ZYME) in Q3 2024, closing a stake of 191,127 shares — an estimated $1.63M sold.

Affinity Asset Advisors first reported a position in ZYME in Q4 2020 and held it in 5 quarters. The position peaked at $3.07M in Q4 2020. 163 funds tracked by Wall St. Rank hold ZYME as of Q3 2024.

  • Affinity Asset Advisors reported no remaining Zymeworks position as of Q3 2024 after selling out during the quarter.
  • Affinity Asset Advisors sold 191,127 Zymeworks shares in Q3 2024, an estimated $1.63M.
  • Affinity Asset Advisors first reported a position in Zymeworks in Q4 2020 and held it in 5 quarters.
  • Affinity Asset Advisors's Zymeworks position peaked at $3.07M in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Zymeworks as of Q3 2024.

Based on Affinity Asset Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.